An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.

Autor: Dharmapuri, S.1, Aurisicchio, L.1, Neuner, P.1, Verdirame, M.1, Ciliberto, G.1, La Monica, N.1 nicola•lamonica@merck.com
Zdroj: Cancer Gene Therapy. May2009, Vol. 16 Issue 5, p462-472. 11p. 8 Graphs.
Databáze: Academic Search Ultimate